These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter? Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427 [TBL] [Abstract][Full Text] [Related]
6. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome]. Bayard S; Cochen De Cock V; Dauvillers Y Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031 [TBL] [Abstract][Full Text] [Related]
7. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease. Valença GT; Glass PG; Negreiros NN; Duarte MB; Ventura LM; Mueller M; Oliveira-Filho J Parkinsonism Relat Disord; 2013 Jul; 19(7):698-700. PubMed ID: 23611687 [TBL] [Abstract][Full Text] [Related]
8. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Voon V; Potenza MN; Thomsen T Curr Opin Neurol; 2007 Aug; 20(4):484-92. PubMed ID: 17620886 [TBL] [Abstract][Full Text] [Related]
9. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease. Drapier D; Drapier S; Sauleau P; Derkinderen P; Damier P; Allain H; Vérin M; Millet B Psychiatry Res; 2006 Nov; 144(2-3):241-4. PubMed ID: 17011634 [TBL] [Abstract][Full Text] [Related]
10. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Joutsa J; Martikainen K; Vahlberg T; Kaasinen V Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693 [TBL] [Abstract][Full Text] [Related]
11. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease. Fenu S; Wardas J; Morelli M Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195 [TBL] [Abstract][Full Text] [Related]
12. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder. Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061 [TBL] [Abstract][Full Text] [Related]
13. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Voon V; Reynolds B; Brezing C; Gallea C; Skaljic M; Ekanayake V; Fernandez H; Potenza MN; Dolan RJ; Hallett M Psychopharmacology (Berl); 2010 Jan; 207(4):645-59. PubMed ID: 19838863 [TBL] [Abstract][Full Text] [Related]
14. Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions. Antonelli F; Ko JH; Miyasaki J; Lang AE; Houle S; Valzania F; Ray NJ; Strafella AP Hum Brain Mapp; 2014 Jun; 35(6):2499-506. PubMed ID: 24038587 [TBL] [Abstract][Full Text] [Related]
15. Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease. van der Vegt JP; Hulme OJ; Zittel S; Madsen KH; Weiss MM; Buhmann C; Bloem BR; Münchau A; Siebner HR Brain; 2013 Apr; 136(Pt 4):1192-203. PubMed ID: 23442226 [TBL] [Abstract][Full Text] [Related]
16. Impulse control disorders and dopaminergic treatments in Parkinson's disease. Villa C; Pascual-Sedano B; Pagonabarraga J; Kulisevsky J Rev Neurol (Paris); 2011 Nov; 167(11):827-32. PubMed ID: 21596410 [TBL] [Abstract][Full Text] [Related]